LOW-VOLUME · SEX-BALANCED
tafluprost Side Effects
tafluprost (also sold as Zioptan) is a LOW-VOLUME FAERS extract #435 of 524 by FAERS report count. Still opens on SEX-BALANCED: 70% of sex-coded reports are female (1,877 F / 795 M).
Data updated 2026-05-15
- 2,845
- FAERS reports
Thinner FAERS book - still a temporal association ledger, not proof of cause. Methodology.
tafluprost reporting skew - 70% of sex-coded reports are female (1,877 F / 795 M). Volume band LOW-VOLUME #435 of 524 by FAERS report count; caseload SIGNAL.
Thinner FAERS extract for tafluprost (Zioptan) (2,845 reports #435 of 524 by FAERS report count). 70% of sex-coded reports are female (1,877 F / 795 M). Sparse books still carry named reaction rows when present; not medical advice.
Counts from the openFDA FAERS extract (2010–2025). Stamps SIGNAL · DEATH-HEAVY · HOSP-LIGHT · SEX-BALANCED.
OCULAR HYPERAEMIA leads 459 of 2,845 reports
Who reports · age peak 75+ (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 75+ (683 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (326 reports, 11.5%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 193 |
| CEREBROVASCULAR ACCIDENT | 14 |
| MYOCARDIAL INFARCTION | 11 |
| CARDIAC FAILURE CONGESTIVE | 10 |
| CORONAVIRUS INFECTION | 10 |
| PARKINSON^S DISEASE | 8 |
| NEOPLASM MALIGNANT | 7 |
| CARDIAC FAILURE | 6 |
| DIABETES MELLITUS | 6 |
| HYPERTENSION | 6 |
| COVID-19 | 5 |
| DEMENTIA | 5 |
| FALL | 5 |
| LUNG NEOPLASM MALIGNANT | 5 |
| PNEUMONIA | 5 |
| RENAL FAILURE | 5 |
| BLADDER CANCER | 4 |
| CONFUSIONAL STATE | 3 |
| DYSPHAGIA | 3 |
Reactions in Hospitalization Reports
Hospitalization is lighter here (275). Reactions in that subset:
| Reaction | Reports |
|---|---|
| DYSPNOEA | 16 |
| FALL | 16 |
| SYNCOPE | 15 |
| DIZZINESS | 11 |
| ARRHYTHMIA | 10 |
| ATRIOVENTRICULAR BLOCK SECOND DEGREE | 10 |
| DRUG INTERACTION | 10 |
| ATRIAL FIBRILLATION | 9 |
| CARDIOVASCULAR INSUFFICIENCY | 9 |
| GOITRE | 9 |
| HEADACHE | 9 |
| HOSPITALISATION | 9 |
| ACUTE KIDNEY INJURY | 8 |
| ATRIOVENTRICULAR BLOCK | 8 |
| BRADYCARDIA | 8 |
| CONSTIPATION | 8 |
| EMPHYSEMA | 8 |
| NAUSEA | 8 |
How to read tafluprost FAERS figures (SIGNAL · DEATH-HEAVY · HOSP-LIGHT)
FAERS holds 2,845 voluntary reports linked to tafluprost (Zioptan), 2010-2025. Death is listed on 326 (11.5%). Hospitalization appears on 275 (9.7%). Top co-reported indication: Glaucoma.
Sparse extract - named reactions and SEX-BALANCED skew still differ by drug; not a complete safety profile.
Read with tafluprost
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-LIGHT stamps.
ABS(total_reports) peer at 2,824 FAERS cases (Δ 21 lighter vs tafluprost); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-LIGHT · SEX-BALANCED.
ABS(total_reports) peer at 2,870 FAERS cases (Δ 25 heavier vs tafluprost); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-LIGHT · SEX-BALANCED.
ABS(total_reports) peer at 2,896 FAERS cases (Δ 51 heavier vs tafluprost); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's SIGNAL · DEATH-HEAVY · HOSP-LIGHT · SEX-BALANCED.
ABS(total_reports) peer at 2,902 FAERS cases (Δ 57 heavier vs tafluprost); DEATH-HEAVY · HOSP-MID · FEMALE-LED vs this page's SIGNAL · DEATH-HEAVY · HOSP-LIGHT · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 50.6 pp vs tafluprost's DEATH-HEAVY): CASELOAD · HOSP-MID.
tafluprost stamps DEATH-HEAVY · HOSP-LIGHT; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload SIGNAL and the label guide.